Director bought
~$1.3KReported value · 1 sh @ $1,285.00
A board member of TransDigm paid $1.3K out of pocket for TransDigm shares. 1 other person at TransDigm bought some too, in the same month.
Loading…
Traded Feb 2, 2026 · Filed Feb 3, 2026
A board member of TransDigm sold $2.15M of TransDigm shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,150,330
Shares × reported transaction price
82 days after results of Nov 12, 2025, 1 day before results of Feb 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,435.52 on Feb 2, 2026, 17% above its 52-week low and 11% below its high, after a 14% rise over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 52% of the way up, from 251 adjusted closes. 30 trading days earlier: $1,261.64 on Dec 17, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.8% | +0.8% | +4.0% |
| 30 days | +2.4% | −2.0% | +4.4% |
| 90 days | −5.8% | +5.5% | −11.3% |
| 180 days | +1.6% | +10.4% | −8.8% |
Past results only. Not a forecast.
A board member of TransDigm paid $1.3K out of pocket for TransDigm shares. 1 other person at TransDigm bought some too, in the same month.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.